WHO ICTRP trial
A Phase III, open, non-randomized, multi-centric, single dose study to assess…
EUCTR2008-001310-24-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-001310-24-DE |
|---|---|
| Public title | A Phase III, open, non-randomized, multi-centric, single dose study to assess immunogenicity and safety of Fluarix™ / Influsplit SSW® 2008/2009 injected intramuscularly in young adults (18 to 60 years) and in elderly (over 60 years). - Fluarix-066 PRI |
| Scientific title | A Phase III, open, non-randomized, multi-centric, single dose study to assess immunogenicity and safety of Fluarix™ / Influsplit SSW® 2008/2009 injected intramuscularly in young adults (18 to 60 years) and in elderly (over 60 years). - Fluarix-066 PRI |
| Primary sponsor | GlaxoSmithKline Biologicals |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Immunization against influenza of healthy adults. |
| Interventions | Trade Name: Fluarix / Influsplit SSW / Alpha-Rix Product Name: Trivalent influenza split vaccine Product Code: FLU Pharmaceutical Form: Suspension for injection INN or Proposed INN: Purified antigen fractions of inactivated influenza… |
| Registration date | Apr 18, 2008 |
| Target size | 120 |
| Secondary IDs | 111631 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: